These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21695251)

  • 1. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study.
    Li F; Finnefrock AC; Dubey SA; Korber BT; Szinger J; Cole S; McElrath MJ; Shiver JW; Casimiro DR; Corey L; Self SG
    PLoS One; 2011; 6(6):e20479. PubMed ID: 21695251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopes.
    Ahmed T; Borthwick NJ; Gilmour J; Hayes P; Dorrell L; Hanke T
    Vaccine; 2016 Feb; 34(9):1215-24. PubMed ID: 26784683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.
    Borthwick N; Ahmed T; Ondondo B; Hayes P; Rose A; Ebrahimsa U; Hayton EJ; Black A; Bridgeman A; Rosario M; Hill AV; Berrie E; Moyle S; Frahm N; Cox J; Colloca S; Nicosia A; Gilmour J; McMichael AJ; Dorrell L; Hanke T
    Mol Ther; 2014 Feb; 22(2):464-475. PubMed ID: 24166483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
    Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
    PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs.
    Paul S; Piontkivska H
    BMC Microbiol; 2010 Aug; 10():212. PubMed ID: 20696039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.
    Almeida RR; Rosa DS; Ribeiro SP; Santana VC; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
    PLoS One; 2012; 7(9):e45267. PubMed ID: 23028895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance.
    Yang OO; Ali A; Kasahara N; Faure-Kumar E; Bae JY; Picker LJ; Park H
    J Virol; 2015 Jan; 89(2):1195-204. PubMed ID: 25378501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
    Horton H; Havenar-Daughton C; Lee D; Moore E; Cao J; McNevin J; Andrus T; Zhu H; Rubin A; Zhu T; Celum C; McElrath MJ
    J Virol; 2006 Oct; 80(19):9779-88. PubMed ID: 16973582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.
    Casazza JP; Bowman KA; Adzaku S; Smith EC; Enama ME; Bailer RT; Price DA; Gostick E; Gordon IJ; Ambrozak DR; Nason MC; Roederer M; Andrews CA; Maldarelli FM; Wiegand A; Kearney MF; Persaud D; Ziemniak C; Gottardo R; Ledgerwood JE; Graham BS; Koup RA;
    J Infect Dis; 2013 Jun; 207(12):1829-40. PubMed ID: 23482645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive epitope mapping using polyclonally expanded human CD8 T cells and a two-step ELISpot assay for testing large peptide libraries.
    Michelo CM; Dalel JA; Hayes P; Fernandez N; Fiore-Gartland A; Kilembe W; Tang J; Streatfield C; Gilmour J; Hunter E
    J Immunol Methods; 2021 Apr; 491():112970. PubMed ID: 33529681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
    Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
    EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
    Mothe B; Hu X; Llano A; Rosati M; Olvera A; Kulkarni V; Valentin A; Alicea C; Pilkington GR; Sardesai NY; Rocafort M; Crespo M; Carrillo J; Marco A; Mullins JI; Dorrell L; Hanke T; Clotet B; Pavlakis GN; Felber BK; Brander C
    J Transl Med; 2015 Feb; 13():60. PubMed ID: 25879820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
    Omosa-Manyonyi G; Mpendo J; Ruzagira E; Kilembe W; Chomba E; Roman F; Bourguignon P; Koutsoukos M; Collard A; Voss G; Laufer D; Stevens G; Hayes P; Clark L; Cormier E; Dally L; Barin B; Ackland J; Syvertsen K; Zachariah D; Anas K; Sayeed E; Lombardo A; Gilmour J; Cox J; Fast P; Priddy F
    PLoS One; 2015; 10(5):e0125954. PubMed ID: 25961283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
    PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.